Wilbert J. Austin Professor of Engineering, Case Western Reserve University
Cleveland, OH
Primary Sector: Academia
Primary Discipline: Engineering
Focus/Research Areas: Government University Industry Research, Global Health and Personalized Health, Future of Health and One Health, Bio Manufacturing, Cell and Gene Therapy
Umut A. Gurkan, Ph.D., is the Wilbert J. Austin Professor of Engineering at Case Western Reserve University. He holds Bachelor of Science degrees in Chemical Engineering and Mechanical Engineering from the Middle East Technical University in Turkey, and a Doctor of Philosophy in Biomedical Engineering from Purdue University. He completed postdoctoral training at Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology. Dr. Gurkan's research emphasizes global equitable access to diagnostics and personalized health. He has authored over 110 peer-reviewed publications, with inventions yielding more than 18 issued United States patents, over 114 international patent applications, and four biotechnology companies producing products for global markets. His innovations have earned awards including recognition from the United States Patent and Trademark Office's Patents for Humanity program and Breakthrough Device Designation from the United States Food and Drug Administration. Additional honors include the American Society of Mechanical Engineers (ASME) Savio L-Y. Woo Translational Biomechanics Medal, the Association for Clinical and Translational Science Distinguished Investigator Award, the Microcirculatory Society Wiederhielm Award, the National Science Foundation CAREER Award, the Translational Research Featured New Investigator Award, the MIT Technology Review Innovator under 35 Award, and the Doris Duke Innovations in Clinical Research Award.Through pioneering work in point-of-care diagnostics and microfluidic technologies, Dr. Gurkan has advanced equitable health access worldwide. His leadership in red blood cell biophysics, hematology, and sickle cell disease has generated fundamental and technical breakthroughs, including microphysiological systems that enhance understanding and treatment of microcirculatory disorders. Focused on sickle cell disease, his developments in microtechnology-enabled products have transformed early screening, diagnosis, and monitoring, especially in resource-limited settings across the United States, Africa, Southeast Asia, the Middle East, and India. Clinical studies in the Global South have improved health outcomes for underserved populations, expanding scientific boundaries while promoting widespread healthcare innovations. Dr. Gurkan is a Senior Member of the National Academy of Inventors (NAI), a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a member of the National Academies of Sciences, Engineering, and Medicine (NASEM) New Voices in Science, Engineering, and Medicine Program (2021–2025). He co-chaired the committee for the 9th Arab-American Frontiers of Science, Engineering, and Medicine Symposium (NASEM, 2023) and served on the planning committee for the workshop "On Leading a Lab: Strengthening Scientific Leadership in Responsible Research" (NASEM), resulting in the publication On Leading a Lab: Strengthening Scientific Leadership in Responsible Research: Proceedings of a Workshop (Washington, DC: The National Academies Press, https://doi.org/10.17226/27935). He was an invited participant in the 5th Arab-American Frontiers Symposium (NASEM, 2017), the 1st U.S.-Africa Frontiers Symposium (NASEM, 2022), and the Government-University-Industry Research Roundtable meeting on "Strategic Innovation and Commercialization: Supporting Intellectual Property and Tech Transfer to Advance U.S. Research Competitiveness" (NASEM, 2023).
Connect: LinkedIn